Not yet recruitingPhase 1NCT07278492

NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome

Studying Down syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Brigham and Women's Hospital
Principal Investigator
Shalender K Bhasin, MB, BS, MD
Brigham and Women's Hosptial
Intervention
MIB-626(drug)
Enrollment
24 enrolled
Eligibility
18 years · All sexes
Timeline
2026 – 2028

Study locations (2)

Collaborators

National Institutes of Health (NIH)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07278492 on ClinicalTrials.gov

Other trials for Down syndrome

Additional recruiting or active studies for the same condition.

See all trials for Down syndrome →

← Back to all trials